ConductScience.org, home

Paper26123787

Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma.

Harada K and 17 others. Dis Esophagus, 2016. Cited by 117 papers, by iCite.

Cite this record

ConductScience Library. Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma. Papers, record 26123787. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26123787

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma.
PubMed
Journal
Dis Esophagus
PubMed
Year
2016
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
117
iCite
Relative citation ratio, by iCite
5.35
iCite
Revised in PubMed
2019-02-21
PubMed

Authors18

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Harada KK
2Ida SS
3Baba YY
4Ishimoto TT
5Kosumi KK
6Tokunaga RR
7Izumi DD
8Ohuchi MM
9Nakamura KK
10Kiyozumi YY
11Imamura YY
12Iwatsuki MM
13Iwagami SS
14Miyamoto YY
15Sakamoto YY
16Yoshida NN
17Watanabe MM
18Baba HH

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anastomotic LeakMajor topic
Carcinoma, Squamous CellMajor topic
ChemoradiotherapyMajor topic
Esophageal NeoplasmsMajor topic
EsophagectomyMajor topic
SarcopeniaMajor topic
Aged
Esophageal Squamous Cell Carcinoma
Female
Humans
Japan
Lymph Nodes
Male
Middle Aged
Muscle, Skeletal
Neoplasm Staging
Postoperative Complications
Prognosis
Retrospective Studies
Survival Rate
Tomography, X-Ray Computed

Source PubMed

Download CSV of topics

Cited by66

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 117 citations.

PMIDTitleJournalYearIn PapersSource
42760927Perioperative phase angle decline is associated with postoperative sarcopenia in esophageal cancer: a longitudinal cohort study with internal validation.Front Nutr2026https://conductscience.org/library/papers/42760927PubMed
42429839Sarcopenia as a prognostic factor in head and neck squamous cell carcinoma: a systematic review and meta-analysis.Eur Radiol2026https://conductscience.org/library/papers/42429839PubMed
41821148Clinical Implications of Nutritional Intake in Patients With Esophageal Squamous Cell Carcinoma Receiving Chemoradiotherapy and Neoadjuvant Chemotherapy.Cancer Med2026https://conductscience.org/library/papers/41821148PubMed
41799582Exercise and Nutrition Prehabilitation Program During Preoperative Chemotherapy Followed by Esophagectomy in Older Patients With Esophageal Cancer: A Randomized Clinical Trial.Ann Gastroenterol Surg2026https://conductscience.org/library/papers/41799582PubMed
41502437Effects of β-hydroxy-β-methylbutyrate on skeletal muscle loss in a mouse model of esophageal squamous cell carcinoma.Ann Transl Med2025https://conductscience.org/library/papers/41502437PubMed
41016991Correlation of growth differentiation factor 15 level in esophageal cancer with cachectic indicators and postoperative infectious complication.Esophagus2026https://conductscience.org/library/papers/41016991PubMed
39883331Low skeletal muscle mass contributes to the prognosis of patients with superficial esophageal cancer treated with definitive chemoradiotherapy.Esophagus2025https://conductscience.org/library/papers/39883331PubMed
39766116Effect of Preoperative Body Composition on Postoperative Anastomotic Leakage in Oncological Ivor Lewis Esophagectomy-A Retrospective Cohort Study.Cancers (Basel)2024https://conductscience.org/library/papers/39766116PubMed
39104037A sarcopenia screening test predicts mortality among hospitalized cancer patients.Physiol Rep2024https://conductscience.org/library/papers/39104037PubMed
37999111Unveiling Therapeutic Targets for Esophageal Cancer: A Comprehensive Review.Curr Oncol2023https://conductscience.org/library/papers/37999111PubMed
37989955Significance of Comprehensive Analysis of Preoperative Sarcopenia Based on Muscle Mass, Muscle Strength, and Physical Function for the Prognosis of Patients with Esophageal Cancer.Ann Surg Oncol2024https://conductscience.org/library/papers/37989955PubMed
37873749May Nutritional Status Positively Affect Disease Progression and Prognosis in Patients with Esophageal and Pharyngeal Cancers? A Scoping Review of the Current Clinical Studies.Med Sci (Basel)2023https://conductscience.org/library/papers/37873749PubMed
37814177The Influence of Strength and Speed on Survival in Esophageal Cancer.Ann Surg Oncol2024https://conductscience.org/library/papers/37814177PubMed
37592262The impact of sarcopenia on esophagectomy for cancer: a systematic review and meta-analysis.BMC Surg2023https://conductscience.org/library/papers/37592262PubMed
37316578Relationship between circulating tumour DNA and skeletal muscle stores at diagnosis of pancreatic ductal adenocarcinoma: a cross-sectional study.Sci Rep2023https://conductscience.org/library/papers/37316578PubMed
37240466Sarcopenia Is a Prognostic Factor in Patients Undergoing Percutaneous Endoscopic Gastrostomy.J Clin Med2023https://conductscience.org/library/papers/37240466PubMed
37101772Sarcopenia Predicts Disease Progression in Patients with T1 High-grade Non-muscle-invasive Bladder Cancer Treated with Adjuvant Intravesical Bacillus Calmette-Guérin: Implications for Decision-making?Eur Urol Open Sci2023https://conductscience.org/library/papers/37101772PubMed
36763134Usefulness of skeletal muscle measurement by computed tomography in patients with esophageal cancer: changes in skeletal muscle mass due to neoadjuvant therapy and the effect on the prognosis.Surg Today2023https://conductscience.org/library/papers/36763134PubMed
36631713Differential prognostic significance of sarcopenia in metastatic esophageal squamous and adenocarcinoma.Esophagus2023https://conductscience.org/library/papers/36631713PubMed
36415154The prognostic value of sarcopenia in oesophageal cancer: A systematic review and meta-analysis.J Cachexia Sarcopenia Muscle2023https://conductscience.org/library/papers/36415154PubMed

See all 66 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26123787

GET https://conductscience.org/api/papers/v1/26123787/cited_by?page=2